Comparative Assessment of Adherence Parameters to Urate-Lowering  Therapy in Patients With Gout

dc.contributor.author	Djuraeva E.R.
dc.date.accessioned	2026-10-20T04:36:37Z
dc.date.available	2026-10-20T04:36:37Z
dc.date.issued	2025-10
dc.identifier.issn	2795-921X
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5526
dc.description.abstract	The study aims to evaluate adherence to urate-lowering therapy (ULT) among patients with gout, to identify factors influencing adherence, and to compare the efficacy and tolerability of allopurinol and febuxostat. A total of 60 patients with a verified gout diagnosis were examined. Adherence was assessed using the Morisky–Green scale. The results demonstrated that more than half of the patients had low or moderate adherence, associated with insufficient awareness and irregular follow-up. Febuxostat showed higher treatment adherence and better achievement of target serum uric acid levels compared with allopurinol. Improving patient education and monitoring is essential for effective gout management.	en_US
dc.language.iso	en_US	en_US
dc.publisher	EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE Vol. 5 No. 10	en_US
dc.subject	gout, urate-lowering therapy, febuxostat, allopurinol.	en_US
dc.title	Comparative Assessment of Adherence Parameters to Urate-Lowering Therapy in Patients With Gout	en_US
dc.type	Article	en_US